Overexpression of CPEB4 is associated with tumor growth, vascularization, migration, invasion and metastasis in breast cancer patients, causing an upregulation of Vimentin expression and promoting EMT, invasion and migration of breast cancer cells. Here, CPEB4 is linked to breast carcinoma.